News

Innovative Partnership in 3D-Printed Seafood Takes Center Stage

Innovative Partnership in 3D-Printed Seafood Takes Center Stage

New Collaboration Between UMAMI Bioworks and Steakholder Foods

UMAMI Bioworks, a pioneering global platform for cultivated seafood, has joined forces with Steakholder Foods (Nasdaq: STKH), a leader in innovative alternative proteins and 3D printing technology. Their partnership has emerged from a two-year research and development collaboration, which was supported by the Singapore-Israel Industrial R&D (SIIRD) grant. This groundbreaking collaboration has paved the way for the mass production of 3D-printed cultivated fish products, setting the stage for commercial opportunities in global seafood markets.

Advancing Sustainable Seafood Through 3D Printing

The joint efforts of UMAMI Bioworks and Steakholder Foods have successfully demonstrated the potential to create premium cultivated fish fillets using advanced 3D printing techniques. This initiative is a significant leap toward a more sustainable seafood industry. Through their collaboration, the companies have developed a portfolio of innovative prototype designs, showcasing the capabilities of 3D printing and cellular cultivation to craft fish products that emulate various seafood species. To enhance their mission, they will also work with Singapore’s National Additive Manufacturing Innovation Cluster (NAMIC). This partnership aims to translate their research into commercially viable seafood products that will cater to both local consumers and international markets.

Strategic Vision from UMAMI Bioworks' Leadership

Mihir Pershad, CEO of UMAMI Bioworks, emphasized the alignment of this collaboration with their vision for a sustainable seafood platform. He stated, "This partnership with Steakholder Foods aligns perfectly with our objective of creating a scalable solution that addresses the global demand for ethical and high-quality seafood alternatives, while also conserving marine biodiversity." This collaborative approach aims to integrate revolutionary 3D printing technology into the existing cultivated seafood production framework, opening new avenues for environmentally conscious seafood sourcing.

Building a Model for Future Partnerships

UMAMI Bioworks and Steakholder Foods are not just advancing their products; they are also pioneering interconnections within cellular agriculture and food technology sectors. As traditional fishing practices contribute significantly to environmental degradation, this collaboration serves as a template for future partnerships focused on transforming the seafood landscape. By combining their strengths, these companies are poised to develop swift commercial solutions that meet the increasing industry demands for sustainable alternatives.

Insights from Steakholder Foods' Leadership

Arik Kaufman, CEO of Steakholder Foods, expressed enthusiasm about the partnership, stating, "Working with UMAMI Bioworks expands our expertise in 3D printing for plant-based seafood into the realm of cultivated products. By combining our skills, we aim to deliver commercial products that fulfill consumer expectations while adhering to environmental and regulatory standards." This collaboration will greatly hasten the development of safe and tasty seafood alternatives.

Aiming for Food Resilience in Singapore

With assistance from NAMIC, the partnership is also focused on developing and refining 3D-printed fish fillets that cater both to local residents and overseas markets. This joint effort strategically prepares both companies to navigate emerging food safety concerns and regulatory guidelines, thereby ensuring that their products can be rapidly integrated into commercial channels.

Support from NAMIC

Dr. Ho Chaw Sing, CEO of NAMIC, highlighted the collaboration's significance in supporting Singapore's food resilience goals, which are part of the nation’s broader initiatives. The aquaculture sector's contribution to these objectives is crucial, and the joint venture aims to enhance the cellular agriculture industry as a sustainable alternative to traditional food production. By utilizing Steakholder Foods' sophisticated 3D printing technology alongside UMAMI Bioworks' cultivated product development expertise, the partnership aspires to deliver seafood options that are comparable in taste and texture to conventional seafood.

About UMAMI Bioworks

UMAMI Bioworks leads in developing sustainable biosolutions for various marketplaces. By harnessing machine learning, multi-omics biomarkers, and digital twins, they have crafted advanced tools for discovering and developing cultivated bioproducts. Their modular production solutions aim to democratize access to sustainable blue bioeconomy resources, addressing pressing global issues.

About Steakholder Foods

Founded in 2019, Steakholder Foods is dedicated to transforming the alternative protein sector through state-of-the-art technology. With a specialization in 3D-printing production systems and proprietary blends of high-quality raw materials, they are focused on equipping manufacturers to efficiently create food products that exceed consumer expectations for quality and sustainability. Their innovations contribute significantly to providing safe and appetizing alternatives to conventional meat and seafood.

Frequently Asked Questions

What is the focus of the collaboration between UMAMI Bioworks and Steakholder Foods?

The collaboration is focused on developing 3D-printed cultivated fish fillets for commercial use, aimed at creating sustainable seafood alternatives.

How does 3D printing contribute to seafood sustainability?

3D printing allows for the production of seafood alternatives that replicate the characteristics of traditional fish, reducing reliance on overfishing and preserving marine ecosystems.

What are the expected benefits of this partnership?

This partnership is expected to commercialize innovative seafood products, enhance food resilience, and promote sustainable practices in the industry.

Who are the main leaders involved in this partnership?

The partnership involves Mihir Pershad, CEO of UMAMI Bioworks, and Arik Kaufman, CEO of Steakholder Foods.

What role does NAMIC play in this initiative?

NAMIC supports the partnership by facilitating the development of 3D-printed fish fillets and helping navigate regulatory frameworks for commercial deployment.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Promising Interim Findings from Medicus Pharma's BCC Study

Updated Category News Views 164

Positive Interim Analysis from Medicus Pharma Ltd Medicus Pharma Ltd. (NASDAQ: MDCX) has recently shared exciting interim results from its SKNJCT-003 Phase 2 clinical study, which focuses on a non-invasive approach to treat basal cell carcinoma (BCC) of the skin. This news marks a significant milestone as the company aims to revolutionize the treatment options available...

Continue Reading
DroneShield's Immediate Response Kit Wins Platinum Award for Innovation

Updated Category News Views 161

DroneShield's Immediate Response Kit Gains Recognition for Innovation DroneShield has recently been awarded the prestigious Platinum Award for Innovation by Military and Aerospace Electronics, showcasing its Immediate Response Kit (IRK) as a cornerstone in drone detection and defeat technology. This award is a testament to the exceptional capabilities of the IRK, which...

Continue Reading
Jefferies Holds ABB Rating; Analysts Assess Mixed Results

Updated Category News Views 65

Jefferies Maintains Hold Rating on ABB Stock Jefferies recently continued its Hold rating for ABB Ltd (NYSE: ABB) and set a price target of CHF50.00, following the company's third-quarter performance report. The report showcased a mixed array of results, with certain metrics outperforming expectations while others showed disappointing trends. During the third quarter, ABB...

Continue Reading
Surgical Clips Market Projected to Reach $1.8 Billion Soon

Updated Category News Views 211

Overview of the Surgical Clips Market Recent analysis of the surgical clips market reveals an impressive valuation of USD 655.9 million in 2023, with projections indicating a potential growth to USD 1.8 billion by 2032. This remarkable increase is attributed to a compound annual growth rate (CAGR) of 11.9% from 2024. Understanding Surgical Clips and Their Importance...

Continue Reading
Public Disclosure of Opening Position by Keywords Studios Plc

Updated Category News Views 74

Public Opening Position Disclosure for Keywords Studios Plc This document provides important information about a public opening position disclosure related to Keywords Studios Plc. It includes details about individuals or entities holding 1% or more of relevant securities. This disclosure is made in accordance with Rule 8.3 of the Takeover Code, which ensures that all...

Continue Reading